NEWS & EVENTS
List
Icon
-
Genovior Biotech Collaboration Expands into the US Market, Signs Product Licensing Agreement to Expand Its Portfolio of Fully Synthetic Peptide PharmaceuticalsMORE >
-
Genovior Biotech Collaboration Signs Exclusive Licensing Agreement with European International Company to Expand Psychiatric Drug Portfolio in the Middle East MarketMORE >
-
Genovior Biotech Corp. 2025 Global Exhibition ScheduleMORE >
-
Zhunan Site Dedicated Oncology(Cytotoxic) Oteracil API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE >
-
Zhunan Site Dedicated Oncology(Cytotoxic) Tegafur API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE >
-
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual- Engine GrowthMORE >